The Effect of Dietetic Treatment on the Serum Lipid Level in Patients with Clinical Signs of Cerebral Arteriosclerosis

1962 ◽  
Vol 4 (4) ◽  
pp. 292-303 ◽  
Author(s):  
S. Eckerström ◽  
L. Svennerholm
Keyword(s):  
Serum Lipid ◽  
Lipid Level ◽  
Clinical Signs ◽  
Serum Lipid Level ◽  
Cerebral Arteriosclerosis ◽  
Dietetic Treatment

Effects of Colpomenia sinuosa Extract on Serum Lipid Level and Bone Formation in Ovariectomized Rats

2016 ◽  
Vol 45 (4) ◽  
pp. 492-500 ◽  
Author(s):  
Juyeong Lee ◽  
Bokyung Kim ◽  
Mi-Hwa Park ◽  
Kyung-Ha Choi ◽  
Changsuk Kong ◽  
...  
Keyword(s):  
Bone Formation ◽  
Serum Lipid ◽  
Lipid Level ◽  
Serum Lipid Level ◽  
Ovariectomized Rats

Role of 5-HT2A Receptor Gene T102C Polymorphism in Coronary Artery Disease and Serum Lipid Level

2003 ◽  
Vol 33 (4) ◽  
pp. 269
Author(s):  
Jin Ho Choi ◽  
Shu Ying Zhang ◽  
Young Seok Cho ◽  
Kyoung Kook Whang ◽  
Jun Hee Lee ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Serum Lipid ◽  
Lipid Level ◽  
Receptor Gene ◽  
Serum Lipid Level ◽  
T102c Polymorphism ◽  
Artery Disease

Effect of Crude Leaves Extract of Bersama Abyssinica on Blood Glucose Level and Serum Lipid Level of Streptozotocin-Induced Diabetic Mice: Evidence for In vivo Antidiabetic Activity

2021 ◽  
Vol 19 ◽  
Author(s):  
Zemene Demelash Kifle ◽  
Agumas Alemu Alehegn ◽  
Baye Yrga Adugna ◽  
Abebe Basazn Mekuria ◽  
Engidaw Fentahun Enyew
Keyword(s):  
Diabetes Mellitus ◽  
Body Weight ◽  
Blood Glucose ◽  
Serum Lipid ◽  
Lipid Level ◽  
Serum Lipid Level ◽  
Diabetic Mice ◽  
Lipid Levels ◽  
Antidiabetic Effect ◽  
Bersama Abyssinica

Background: Diabetes mellitus is one of the major and common metabolic, and chronic disorders in the world. Several medicinal plants have been used globally for the management of diabetes mellitus. The current study aimed to study the anti-hyperglycemic and anti-hyperlipidemic effects of Bersama abyssinica. Methods: Antidiabetic effect of 80% methanolic crude extract of Bersama abyssinica was studied in repeated dose-treated STZ-induced diabetic mice model. The activities of Bersama abyssinica on serum lipid level and body weight were investigated on STZ-induced diabetic mice. Data were analyzed using one-way ANOVA and significant when the p-value was less than 0.05. Results: All doses of the crude 80% methanolic extract of Bersama abyssinica (100 mg/kg, 200 mg/kg, and 400 mg/kg) exhibited a noticeable BGL reduction when compared with baseline blood glucose level and diabetic control on the 7th and 14th days of administration. Moreover, the higher dose of the extract (at 400 mg/kg) significantly (p < 0.001, 54.3%) decreased the BGL in STZ-induced diabetic mice. The maximum decrement in fasting BGL was achieved at the 14th days: 34.92%, 41.10%, 54.30%, and 59.66%, respectively for BAC 100 mg/kg, BAC 200 mg/kg, BAC 400 mg/kg, and GLC 5 mg/kg treated groups. Bersama abyssinica also displayed a significant (p < 0.05) improvement of serum lipid levels and body weight. Conclusion: Bersama abyssinica crude extract exhibited a significant antidiabetic effect and prevented body weight loss in streptozotocin-induced diabetic mice. The finding also confirmed the valuable biochemical activity of Bersama abyssinica by improving serum lipid levels.

Sign in / Sign up

Export Citation Format

Share Document